FarmaMondo, ExCellThera and Cordex have entered into a commercial partnership to expand access to Zemcelpro® in Singapore, Hong Kong and Argentina, initially through Named Patient Sales. The collaboration aims to address unmet medical needs by providing eligible patients with blood cancers who lack a suitable matched donor access to an innovative stem cell therapy with potentially curative intent.

FarmaMondo Group, an international commercial pharmaceutical organization that partners with pharma and biotech to deliver innovative and specialty medicines to the 50+ emerging markets, today announces the appointment of Natalie Douglas as Independent Board Director.

FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.